Search research articles
Contact Us
Filters
Showing results (21-30 of 166) with videos related to
Page
of 17
Sort By:
Current Topics in Developmental Biology
|
February 3, 2009
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies
Glen B Banks, Jeffrey S Chamberlain
Nature Medicine
|
October 9, 2019
Surrogate gene therapy for muscular dystrophy
Kay E Davies, Jeffrey S Chamberlain
Molecular Therapy. Nucleic Acids
|
December 2, 2025
Genetic strategies for therapy of Duchenne muscular dystrophy
Agnieszka Łoboda, Jeffrey S Chamberlain, Józef Dulak
Methods in Molecular Medicine
|
January 16, 2003
Packaging cell lines for generating replication-defective and gutted adenoviral vectors
Jeffrey S Chamberlain, Catherine Barjot, Jeannine Scott
Muscle & Nerve
|
April 5, 2013
Gene and cell-mediated therapies for muscular dystrophy
Patryk Konieczny, Kristy Swiderski, Jeffrey S Chamberlain
Biochimica Et Biophysica Acta
|
October 27, 2006
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances
Guy L Odom, Paul Gregorevic, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 20, 2005
Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors
Michael J Blankinship, Paul Gregorevic, Jeffrey S Chamberlain
Current Opinion in Molecular Therapeutics
|
November 13, 2004
Viral vectors for gene transfer to striated muscle
Paul Gregorevic, Michael J Blankinship, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2025
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy
Niclas E Bengtsson, Hichem Tasfaout, Jeffrey S Chamberlain
Journal of Cell Science
|
March 30, 2006
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
Luke M Judge, Miki Haraguchiln, Jeffrey S Chamberlain
Page
of 17
Search research articles
Search
Showing results (21-30 of 166) with videos related to
Sort By:
Page
of 17
Current Topics in Developmental Biology
|
February 3, 2009
The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies
Glen B Banks, Jeffrey S Chamberlain
Nature Medicine
|
October 9, 2019
Surrogate gene therapy for muscular dystrophy
Kay E Davies, Jeffrey S Chamberlain
Molecular Therapy. Nucleic Acids
|
December 2, 2025
Genetic strategies for therapy of Duchenne muscular dystrophy
Agnieszka Łoboda, Jeffrey S Chamberlain, Józef Dulak
Methods in Molecular Medicine
|
January 16, 2003
Packaging cell lines for generating replication-defective and gutted adenoviral vectors
Jeffrey S Chamberlain, Catherine Barjot, Jeannine Scott
Muscle & Nerve
|
April 5, 2013
Gene and cell-mediated therapies for muscular dystrophy
Patryk Konieczny, Kristy Swiderski, Jeffrey S Chamberlain
Biochimica Et Biophysica Acta
|
October 27, 2006
Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances
Guy L Odom, Paul Gregorevic, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 20, 2005
Gene therapy strategies for Duchenne muscular dystrophy utilizing recombinant adeno-associated virus vectors
Michael J Blankinship, Paul Gregorevic, Jeffrey S Chamberlain
Current Opinion in Molecular Therapeutics
|
November 13, 2004
Viral vectors for gene transfer to striated muscle
Paul Gregorevic, Michael J Blankinship, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 4, 2025
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy
Niclas E Bengtsson, Hichem Tasfaout, Jeffrey S Chamberlain
Journal of Cell Science
|
March 30, 2006
Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex
Luke M Judge, Miki Haraguchiln, Jeffrey S Chamberlain
Page
of 17